ARA-290
Cibinetide
An 11-amino-acid peptide derived from the structure of erythropoietin (Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH), engineered to interact with the innate repair receptor without erythropoietin's hematopoietic activity — meaning research can examine EPO's tissue-protective signaling in isolation from its effect on red blood cell production.
What researchers are studying ARA-290 for.
Innate Repair Receptor Signaling
Anti-Inflammatory & Tissue-Protective Research
Peripheral Nerve & Pain-Signaling Research
Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH
Concentration and unit math, worked out.
Worked example for a 4mg vial reconstituted with 3mL of bacteriostatic water, drawn on a U-100 insulin syringe. Use the calculator below for any other vial size or water volume.
| UNITS DRAWN | VOLUME | DELIVERS |
|---|---|---|
| 5 units | 0.05 mL | 67 mcg |
| 10 units | 0.10 mL | 133 mcg |
| 20 units | 0.20 mL | 267 mcg |
| 30 units | 0.30 mL | 400 mcg |
| 50 units | 0.50 mL | 667 mcg |
Run your own numbers.
Pre-filled with a 30-day starting point — one vial, dosed once daily for 30 days. Adjust any field to match your own protocol.
RESULTS
Educational reference tool only — not medical advice. Reconstitution and dosing decisions for any research protocol should be reviewed with a qualified professional. Figures assume uniform mixing and standard syringe calibration; always verify against your own protocol.